Skip to content

Amplitude Healthcare (AMHC) Stock Surges As Shareholders Approve Jasper Therapeutics Merger

Sam Boughedda
Sam Boughedda trader
Updated 23 Sep 2021

Amplitude Healthcare Acquisition Corporation (Nasdaq: AMHC), a special purpose acquisition company, has seen its shares surge premarket after announcing that its stockholders voted to approve the business combination with Jasper Therapeutics.


Shareholders approved the business combination with Jasper, a biotechnology company, with 74.9% of the approximately 9.9 million votes in favour.

Holders of 9,262,099 shares of AMHC Class A common stock have chosen to redeem their shares, and as a result, Jasper has agreed to waive the requirement that the amount of cash available in AMHC’s trust account is at least $130 million.

Following the announcement, AMHC’s share price rose over 73% to $17.75 premarket, making it one of the biggest movers ahead of the opening bell.

After the close of the SPAC merger, the combined company will operate under the name Jasper Therapeutics, Inc with its shares trading on the Nasdaq Capital Market.

Should You Invest in AMHC Shares?

One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now

Sam Boughedda
Sam is a trader and lead stock market writer at AskTraders. After starting his career in the forex market, Sam now focuses on stocks, specifically consumer staples.